open access

Vol 8, No 2 (2023)
Letter to the Editor
Published online: 2023-03-07
Get Citation

Biomarkers levels indicate COVID-19 severity and fatality

Sergii Nasheda1, Alla Navolokina1, Ivanna Hrytsan1
·
Disaster Emerg Med J 2023;8(2):122-123.
Affiliations
  1. European School of Medicine, International European University, Kyiv, Ukraine

open access

Vol 8, No 2 (2023)
LETTERS TO THE EDITOR
Published online: 2023-03-07

Abstract

Not available

Abstract

Not available
Get Citation

Keywords

D-dimer; biomarker; COVID-19; SARS-CoV-2; severity; outcome

About this article
Title

Biomarkers levels indicate COVID-19 severity and fatality

Journal

Disaster and Emergency Medicine Journal

Issue

Vol 8, No 2 (2023)

Article type

Letter to the Editor

Pages

122-123

Published online

2023-03-07

Page views

1169

Article views/downloads

231

DOI

10.5603/DEMJ.a2023.0007

Bibliographic record

Disaster Emerg Med J 2023;8(2):122-123.

Keywords

D-dimer
biomarker
COVID-19
SARS-CoV-2
severity
outcome

Authors

Sergii Nasheda
Alla Navolokina
Ivanna Hrytsan

References (10)
  1. Kilic M, Hokenek UD. Association between D-dimer and mortality in COVID-19 patients: a single center study from a Turkish hospital. Disaster Emerg Med J. 2022; 7(4): 225–230.
  2. Tian W, Jiang W, Yao J, et al. Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis. J Med Virol. 2020; 92(10): 1875–1883.
  3. Matuszewski M, Szarpak L, Rafique Z, et al. Prediction value of KREBS von den lungen-6 (KL-6) biomarker in COVID-19 patients: A systematic review and meta-analysis. J Clin Med. 2022; 11(21).
  4. Dubey L, Dorosh O, Dubey N, et al. COVID-19-induced coagulopathy: Experience, achievements, prospects. Cardiol J. 2023 [Epub ahead of print].
  5. Restrepo MI, Marin-Corral J, Rodriguez JJ, et al. Cardiovascular complications in coronavirus disease 2019-pathogenesis and management. Semin Respir Crit Care Med. 2023; 44(1): 21–34.
  6. Zhang L, Yan X, Fan Q, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost. 2020; 18(6): 1324–1329.
  7. Malik P, Patel U, Mehta D, et al. Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis. BMJ Evid Based Med. 2021; 26(3): 107–108.
  8. Szarpak Ł, Nowak B, Kosior D, et al. Cytokines as predictors of COVID-19 severity: evidence from a meta-analysis. Pol Arch Intern Med. 2021; 131(1): 98–99.
  9. Szarpak L, Ruetzler K, Safiejko K, et al. Lactate dehydrogenase level as a COVID-19 severity marker. Am J Emerg Med. 2021; 45: 638–639.
  10. Zheng Z, Peng F, Xu B, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 2020; 81(2): e16–e25.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl